Global Drug Delivery Devices Market

Drug Delivery Devices Market Size, Share, Growth Analysis, By Route of Administration (Oral, Injectable), By Application (Oncology, Infectious Diseases), By End-use (Hospitals, Diagnostic Centers), By Region -Industry Forecast 2024-2031.

Report ID: SQMIG35A2918 | Region: Global | Published Date: October, 2024
Pages: 212 | Tables: 97 | Figures: 70

Drug Delivery Devices Market Competitive Landscape

The market is moderately fragmented with the presence of several local companies. These market players are striving to gain higher market share by adopting strategies, such as investments, partnerships, and acquisitions & mergers. Companies are also spending money on the development of improved products. Moreover, they are also focusing on maintaining competitive pricing. This requires constant research and development initiatives to stay ahead in this ever-changing business setting.

Top Player’s Company Profile

  • Pfizer, Inc.  
  • Novartis AG  
  • BD  
  • Bayer AG  
  • UniQure N.V.  
  • Sibiono GeneTech Co. Ltd.  
  • West Pharmaceutical Services Inc.  
  • Merck  
  • Teva Pharmaceutical Industries Ltd  
  • GlaxoSmithKline PLC  
  • Holozymes Inc.  
  • Altaris  
  • Elcam Medical  
  • Fresenius Medical Care  
  • Philips Healthcare  
  • Novo Nordisk  
  • Teva Pharmaceutical  
  • Eli Lilly and Company  
  • CSL Behring  
  • Amgen Inc.
$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Global Drug Delivery Devices Market size was valued at USD 262.30 billion in 2022 and is poised to grow from USD 277.78 billion in 2023 to USD 439.40 billion by 2031, growing at a CAGR of 5.90% during the forecast period (2024-2031).

The market is moderately fragmented with the presence of several local companies. These market players are striving to gain higher market share by adopting strategies, such as investments, partnerships, and acquisitions & mergers. Companies are also spending money on the development of improved products. Moreover, they are also focusing on maintaining competitive pricing. This requires constant research and development initiatives to stay ahead in this ever-changing business setting. 'Pfizer, Inc.  ', 'Novartis AG  ', 'BD  ', 'Bayer AG  ', 'UniQure N.V.  ', 'Sibiono GeneTech Co. Ltd.  ', 'West Pharmaceutical Services Inc.  ', 'Merck  ', 'Teva Pharmaceutical Industries Ltd  ', 'GlaxoSmithKline PLC  ', 'Holozymes Inc.  ', 'Altaris  ', 'Elcam Medical  ', 'Fresenius Medical Care  ', 'Philips Healthcare  ', 'Novo Nordisk  ', 'Teva Pharmaceutical  ', 'Eli Lilly and Company  ', 'CSL Behring  ', 'Amgen Inc.'

Increasing Government Investments on Healthcare

Increasing Emphasis on Biosimilar and Biologics: The market for subcutaneous drug delivery devices is being driven by the rising demand for biosimilars and biologics, which frequently need to be administered subcutaneously. Subcutaneous administration offers a practical and efficient way to provide biologics and biosimilars, which offer focused therapy for complex disorders.

North America is dominating the drug delivery devices market with maximum market share. This can be attributed to the presence of major players in the region and growing adoption of drug supply devices. Moreover, increasing awareness in the region regarding the advantages of drug delivery devices is also expected to boost the market growth in the region. In addition, growing product approval in countries such as U.S. is also expected to contribute toward the market growth. Moreover, favorable reimbursement policies for specialty drugs and devices can increase the affordability of treatment. Significant R&D investments by device manufacturers towards innovative devices for injectable and inhaled drugs can drive the market growth

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

Click here right-arrow
logo-images

Feedback From Our Clients

Global Drug Delivery Devices Market

Report ID: SQMIG35A2918

$5,300
BUY NOW GET FREE SAMPLE